These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 39085036

  • 1. Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases.
    Weisser B, Wassmann S, Predel HG, Schmieder RE, Gillessen A, Wilke T, Blettenberg J, Randerath O, Mevius A, Böhm M.
    Eur Heart J Cardiovasc Pharmacother; 2024 Jul 31. PubMed ID: 39085036
    [Abstract] [Full Text] [Related]

  • 2. Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study.
    Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, Maywald U, Randerath O, Mueller S, Böhm M.
    Integr Blood Press Control; 2022 Jul 31; 15():11-21. PubMed ID: 35250308
    [Abstract] [Full Text] [Related]

  • 3. A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination.
    Masi S, Kobalava Z, Veronesi C, Giacomini E, Degli Esposti L, Tsioufis K.
    Adv Ther; 2024 Jan 31; 41(1):182-197. PubMed ID: 37864626
    [Abstract] [Full Text] [Related]

  • 4. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
    Sicras Mainar A, Galera Llorca J, Muñoz Ortí G, Navarro Artieda R.
    Med Clin (Barc); 2011 Feb 26; 136(5):183-91. PubMed ID: 21106209
    [Abstract] [Full Text] [Related]

  • 5. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B, Predel HG, Gillessen A, Hacke C, Vor dem Esche J, Rippin G, Noetel A, Randerath O.
    High Blood Press Cardiovasc Prev; 2020 Apr 26; 27(2):157-164. PubMed ID: 32219670
    [Abstract] [Full Text] [Related]

  • 6. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec 26; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 7. Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany.
    Wilke T, Weisser B, Predel HG, Schmieder RE, Wassmann S, Gillessen A, Blettenberg J, Maywald U, Randerath O, Müller S, Böhm M.
    J Comp Eff Res; 2022 Apr 26; 11(6):411-422. PubMed ID: 35315281
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study.
    Morabito G, Gregorio C, Ieva F, Barbati G, Mancia G, Corrao G, Rea F.
    BMC Public Health; 2024 Jul 06; 24(1):1808. PubMed ID: 38971775
    [Abstract] [Full Text] [Related]

  • 9. Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis.
    Lo HY, Lin YS, Lin DS, Lee JK, Chen WJ.
    JAMA Netw Open; 2022 Sep 01; 5(9):e2229706. PubMed ID: 36048442
    [Abstract] [Full Text] [Related]

  • 10. Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study.
    Kim SJ, Kwon OD, Cho B, Oh SW, Lee CM, Choi HC.
    BMJ Open; 2019 Jun 22; 9(6):e029862. PubMed ID: 31230034
    [Abstract] [Full Text] [Related]

  • 11. Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
    Schmieder RE, Wassmann S, Predel HG, Weisser B, Blettenberg J, Gillessen A, Randerath O, Mevius A, Wilke T, Böhm M.
    Hypertension; 2023 May 22; 80(5):1127-1135. PubMed ID: 36987918
    [Abstract] [Full Text] [Related]

  • 12. A real-world analysis of adherence, biochemical outcomes, and healthcare costs in patients treated with rosuvastatin/ezetimibe as single-pill combination vs. free combination in Italy.
    Zambon A, Liberopoulos E, Dovizio M, Veronesi C, Degli Esposti L, Pérez de Isla L.
    Eur Heart J Open; 2024 Sep 22; 4(5):oeae074. PubMed ID: 39310723
    [Abstract] [Full Text] [Related]

  • 13. Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.
    Chapman RH, Yeaw J, Roberts CS.
    BMC Cardiovasc Disord; 2010 Jun 17; 10():29. PubMed ID: 20565779
    [Abstract] [Full Text] [Related]

  • 14. Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both.
    Nguyen C, Luthra R, Kuti E, Willey VJ.
    Curr Med Res Opin; 2020 Dec 17; 36(12):1927-1938. PubMed ID: 33023310
    [Abstract] [Full Text] [Related]

  • 15. Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy.
    Yang W, Kahler KH, Fellers T, Orloff J, Chang J, Bensimon AG, Wu EQ, Fan CP, Yu AP.
    J Med Econ; 2011 Dec 17; 14(3):267-78. PubMed ID: 21446895
    [Abstract] [Full Text] [Related]

  • 16. Projecting the long-term benefits of single pill combination therapy for patients with hypertension in five countries.
    Borghi C, Wang J, Rodionov AV, Rosas M, Sohn IS, Alcocer L, Valentine WJ, Deroche-Chibedi D, Granados D, Croce D.
    Int J Cardiol Cardiovasc Risk Prev; 2021 Sep 17; 10():200102. PubMed ID: 35112114
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials.
    Galli M, Capodanno D, Benenati S, D'Amario D, Crea F, Andreotti F, Angiolillo DJ.
    Eur Heart J Cardiovasc Pharmacother; 2022 Aug 11; 8(5):519-528. PubMed ID: 34146091
    [Abstract] [Full Text] [Related]

  • 18. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ, HF-ACTION Investigators.
    Clin Cardiol; 2013 Oct 11; 36(10):611-20. PubMed ID: 23929781
    [Abstract] [Full Text] [Related]

  • 19. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Oct 11; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 20. Epilepsy and the risk of adverse cardiovascular events: A nationwide cohort study.
    Mayer J, Fawzy AM, Bisson A, Pasi M, Bodin A, Vigny P, Herbert J, Marson AG, Lip GYH, Fauchier L.
    Eur J Neurol; 2024 Mar 11; 31(3):e16116. PubMed ID: 38165065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.